GlobeImmune(GBIM)- NASDAQ
Company Description
GlobeImmune, Inc. is a biopharmaceutical company, which focuses on developing therapeutic products for cancer and infectious diseases based on its proprietary Tarmogen platform. The company was founded by Donald Bellgrau, Richard C. Duke and Alex Franzusoff on February 10, 1995 and is... More
Sector: Healthcare
Industry: Biotechnology
Country: United States